Developing Molecular Targeted Radiation as Drug Therapy for Cancer

Radimmune Therapeutics is a start up biotechnology company whose expert multidisciplinary management team is committed to fostering research and development in molecular targeted radiotherapy (formerly known as radio immunotherapy).  Our vision is that molecular targeted drug therapy has significant untapped potential for offering effective, low toxicity drugs to the oncology market.